TEST BANK
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
Author: Teri Moser Woo and Wendy L. Wright
, TABLE OF CONTENT
n, n,
Chapter n,1. n,The n,Role n,of n,the n,Advanced n,Practice n,Nurse n,as n,Prescriber ............................................................. 4
Chapter n,2. n,Review n,of n,Basic n,Principles n,of n,Pharmacology .............................................................................. 5
Chapter n,3. n,Rational n,Drug n,Selection .............................................................................................................. 11
Chapter n,4. n,Legal n,and n,Professional n,Issues n,in n,Prescribing ............................................................................. 14
Chapter n,5. n,Adverse n,Drug n,Reactions ............................................................................................................. 16
Chapter n,6. n,An n,Introduction n,to n,Pharmacogenomics ....................................................................................... 19
Chapter n,7. n,Nutrition n,and n,Nutraceuticals ....................................................................................................... 22
Chapter n,8. n,Herbal n,Therapies ......................................................................................................................... 28
Chapter n,9. n,Cannabis ...................................................................................................................................... 31
Chapter n,10. n,Pharmacoeconomics ................................................................................................................... 35
Chapter n,11. n,Drugs n,Affecting n,the n,Autonomic n,Nervous n,System .................................................................... 38
Chapter n,12. n,Drugs n,Affecting n,the n,Central n,Nervous n,System .......................................................................... 45
Chapter n,13. n,Drugs n,Affecting n,the n,Cardiovascular n,and n,Renal n,Systems ......................................................... 53
Chapter n,14. n,Drugs n,Affecting n,the n,Respiratory n,System .................................................................................. 61
Chapter n,15. n,Drugs n,Affecting n,the n,Hematological n,System ............................................................................. 65
Chapter n,16. n,Drugs n,Affecting n,the n,Immune n,System: n,Vaccines n,and n,Immunoglobulins ................................... 69
Chapter n,17. n,Drugs n,Affecting n,the n,Immune n,System: n,Immunomodulators ...................................................... 75
Chapter n,18. n,Drugs n,Affecting n,the n,Gastrointestinal n,System............................................................................ 77
Chapter n,19. n,Drugs n,Affecting n,the n,Endocrine n,System: n,Pancreatic n,Hormones n,and n,Antidiabetic n,Drugs ............ 80
Chapter n,20. n,Drugs n,Affecting n,the n,Endocrine n,System: n,Pituitary, n,Thyroid, n,and n,Adrenal n,Drugs..................... 83
Chapter n,21. n,Drugs n,Affecting n,the n,Reproductive n,System ............................................................................... 86
Chapter n,22. n,Drugs n,Affecting n,the n,Bones n,and n,Joints ..................................................................................... 92
Chapter n,23. n,Drugs n,Affecting n,the n,Integumentary n,System.............................................................................. 96
Chapter n,24. n,Drugs n,Used n,to n,Treat n,Bacterial n,Infections ............................................................................... 101
Chapter n,25. n,Drugs n,Used n,to n,Treat n,Viral, n,Fungal, n,and n,Protozoal n,Infections ............................................... 105
Chapter n,26. n,Drugs n,Used n,to n,Treat n,Inflammatory n,Processes ........................................................................ 108
Chapter n,27. n,Drugs n,Used n,to n,Treat n,Eye n,and n,Ear n,Disorders ......................................................................... 111
Chapter n,28. n,Anemia .................................................................................................................................... 113
Chapter n,29. n,Anxiety n,and n,Depression .......................................................................................................... 116
Chapter n,30. n,Attention n,Deficit-Hyperactivity n,Disorder ................................................................................ 120
Chapter n,31. n,Asthma n,and n,Allergy................................................................................................................ 122
Chapter n,32. n,Chronic n,Obstructive n,Pulmonary n,Disease................................................................................. 125
Chapter n,33. n,Contraception........................................................................................................................... 127
Chapter n,34. n,COVID-19: n,Acute n,and n,Chronic .............................................................................................. 130
Chapter n,35. n,Dermatological n,Conditions ...................................................................................................... 134
Chapter n,36. n,Diabetes n,Management ............................................................................................................. 138
Chapter n,37. n,Gastroesophageal n,Reflux n,and n,Peptic n,Ulcer n,Disease ............................................................... 146
Chapter n,38. n,Headaches................................................................................................................................ 149
Chapter n,39. n,Heart n,Failure ........................................................................................................................... 153
Chapter n,40. n,HIV n,Disease n,and n,Acquired n,Immunodeficiency n,Syndrome ..................................................... 158
Chapter n,41. n,Menopausal n,Hormone n,Therapy ............................................................................................... 161
,Chapter n,42. n,Hyperlipidemia ........................................................................................................................ 164
Chapter n,43. n,Hypertension............................................................................................................................ 169
Chapter n,44. n,Hyperthyroidism n,and n,Hypothyroidism .................................................................................... 174
Chapter n,45. n,Obesity .................................................................................................................................... 177
Chapter n,46. n,Pain n,Management: n,Acute n,and n,Chronic n,Pain........................................................................... 181
Chapter n,47. n,Pneumonia ............................................................................................................................... 185
Chapter n,48. n,Sexually n,Tr n,ANS n,mitted n,Diseases n,and n,Vaginitis ................................................................... 187
Chapter n,49. n,Substance n,Use n,Disorders......................................................................................................... 190
Chapter n,50. n,Tuberculosis ............................................................................................................................ 195
Chapter n,51. n,Upper n,Respiratory n,Tract n,Infection, n,Pharyngitis, n,Sinusitis, n,Otitis n,Media, n,and n,Otitis n,Externa ... 197
Chapter n,52. n,Urinary n,Tract n,Infections.......................................................................................................... 200
Chapter n,53. n,Women n,as n,Patients.................................................................................................................. 203
Chapter n,54. n,Men n,as n,Patients....................................................................................................................... 207
Chapter n,55. n,Pediatric n,Patients ..................................................................................................................... 209
Chapter n,57. n,Geriatric n,Patients ..................................................................................................................... 213
, 1
Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
n, n, n, n, n, n, n, n, n, n,
MULTIPLE n,CHOICE
1. Nurse n,practitioner n,prescriptive n,authority n,is n,regulated n,by:
A. The n,National n,Council n,of n,State n,Boards n,of n,Nursing
B. The n,U.S. n,Drug n,Enforcement n,Administration
C. The n,State n,Board n,of n,Nursing n,for n,each n,state
D. The n,State n,Board n,of n,Pharmacy
n, ANS n,: n , C PTS: n , n, 1
2. The n,benefits n,to n,the n,patient n,ofn,having n,an n,advanced n,practice n,registered n,nurse n,(APRN)
prescriber n,include:
n,
A. Nurses n,know n,more n,about n,pharmacology n,than n,other n,prescribers n,because n,they n,take
n,it n, both n, in n,their n, basic n, nursing n,program n,and n, in n,their n, APRN n,program.
B. Nurses n,care n,for n,the n,patient n,from n,a n,holistic n,approach n,and n,include n,the
n,patient n,in n,decision-making n,regarding n,their n,care.
C. APRNs n,are n,less n,likely n,to n,prescribe n,narcotics n,and n,other n,controlledn,substances.
D. APRNs n,are n,able n,to n,prescribe n,independently n,in n,all n,states, n,whereas n,a
n,physician’s n,assistant n, needs n,to n,have n, a n,physician n, supervising n,their n,practice.
n, ANS n,: n , B PTS: n , n, 1
3. Clinical n,judgment n,in n,prescribing n,includes:
A. Factoring n,in n,the n,cost n,to n,the n,patient n,of n,the n,medication n,prescribed
B. Always n,prescribing n,the n,newest n,medication n,available n,for n,the n,disease n,process
C. Handing n,out n,drug n,samples n,to n,poor n,patients
D. Prescribing n,all n,generic n,medications n,to n,cut n,costs
n, ANS n,: n , A PTS: n , n, 1
4. The n,process n,for n,choosing n,an n,effective n,drug n,for n,a n,disorder n,includes:
A. Asking n,the n,patient n,what n,drug n,they n,think n,would n,work n,best n,for n,them
B. Consulting n,nationally n,recognized n,guidelines n,for n,disease n,management
C. Prescribing n,medications n,that n,are n,available n,as n,samples n,before n,writing n,a n,prescription
D. Following n,U.S. n,Drug n,Enforcement n,Administration n,guidelines n,for n,prescribing
n, ANS n,: n , B PTS: n , n, 1
5. Nonintentional n,nonadherence n,of n,drug n,therapy n,may n,occur n,due n,to:
A. Belief n,that n,medication n,does n,not n,work
B. Adverse n,drug n,reactions
C. Chronic n,conditions n,that n,require n,daily n,therapy
D. Forgetfulness n,or n,distraction
n, ANS n,: n , D PTS: n , n, 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
Author: Teri Moser Woo and Wendy L. Wright
, TABLE OF CONTENT
n, n,
Chapter n,1. n,The n,Role n,of n,the n,Advanced n,Practice n,Nurse n,as n,Prescriber ............................................................. 4
Chapter n,2. n,Review n,of n,Basic n,Principles n,of n,Pharmacology .............................................................................. 5
Chapter n,3. n,Rational n,Drug n,Selection .............................................................................................................. 11
Chapter n,4. n,Legal n,and n,Professional n,Issues n,in n,Prescribing ............................................................................. 14
Chapter n,5. n,Adverse n,Drug n,Reactions ............................................................................................................. 16
Chapter n,6. n,An n,Introduction n,to n,Pharmacogenomics ....................................................................................... 19
Chapter n,7. n,Nutrition n,and n,Nutraceuticals ....................................................................................................... 22
Chapter n,8. n,Herbal n,Therapies ......................................................................................................................... 28
Chapter n,9. n,Cannabis ...................................................................................................................................... 31
Chapter n,10. n,Pharmacoeconomics ................................................................................................................... 35
Chapter n,11. n,Drugs n,Affecting n,the n,Autonomic n,Nervous n,System .................................................................... 38
Chapter n,12. n,Drugs n,Affecting n,the n,Central n,Nervous n,System .......................................................................... 45
Chapter n,13. n,Drugs n,Affecting n,the n,Cardiovascular n,and n,Renal n,Systems ......................................................... 53
Chapter n,14. n,Drugs n,Affecting n,the n,Respiratory n,System .................................................................................. 61
Chapter n,15. n,Drugs n,Affecting n,the n,Hematological n,System ............................................................................. 65
Chapter n,16. n,Drugs n,Affecting n,the n,Immune n,System: n,Vaccines n,and n,Immunoglobulins ................................... 69
Chapter n,17. n,Drugs n,Affecting n,the n,Immune n,System: n,Immunomodulators ...................................................... 75
Chapter n,18. n,Drugs n,Affecting n,the n,Gastrointestinal n,System............................................................................ 77
Chapter n,19. n,Drugs n,Affecting n,the n,Endocrine n,System: n,Pancreatic n,Hormones n,and n,Antidiabetic n,Drugs ............ 80
Chapter n,20. n,Drugs n,Affecting n,the n,Endocrine n,System: n,Pituitary, n,Thyroid, n,and n,Adrenal n,Drugs..................... 83
Chapter n,21. n,Drugs n,Affecting n,the n,Reproductive n,System ............................................................................... 86
Chapter n,22. n,Drugs n,Affecting n,the n,Bones n,and n,Joints ..................................................................................... 92
Chapter n,23. n,Drugs n,Affecting n,the n,Integumentary n,System.............................................................................. 96
Chapter n,24. n,Drugs n,Used n,to n,Treat n,Bacterial n,Infections ............................................................................... 101
Chapter n,25. n,Drugs n,Used n,to n,Treat n,Viral, n,Fungal, n,and n,Protozoal n,Infections ............................................... 105
Chapter n,26. n,Drugs n,Used n,to n,Treat n,Inflammatory n,Processes ........................................................................ 108
Chapter n,27. n,Drugs n,Used n,to n,Treat n,Eye n,and n,Ear n,Disorders ......................................................................... 111
Chapter n,28. n,Anemia .................................................................................................................................... 113
Chapter n,29. n,Anxiety n,and n,Depression .......................................................................................................... 116
Chapter n,30. n,Attention n,Deficit-Hyperactivity n,Disorder ................................................................................ 120
Chapter n,31. n,Asthma n,and n,Allergy................................................................................................................ 122
Chapter n,32. n,Chronic n,Obstructive n,Pulmonary n,Disease................................................................................. 125
Chapter n,33. n,Contraception........................................................................................................................... 127
Chapter n,34. n,COVID-19: n,Acute n,and n,Chronic .............................................................................................. 130
Chapter n,35. n,Dermatological n,Conditions ...................................................................................................... 134
Chapter n,36. n,Diabetes n,Management ............................................................................................................. 138
Chapter n,37. n,Gastroesophageal n,Reflux n,and n,Peptic n,Ulcer n,Disease ............................................................... 146
Chapter n,38. n,Headaches................................................................................................................................ 149
Chapter n,39. n,Heart n,Failure ........................................................................................................................... 153
Chapter n,40. n,HIV n,Disease n,and n,Acquired n,Immunodeficiency n,Syndrome ..................................................... 158
Chapter n,41. n,Menopausal n,Hormone n,Therapy ............................................................................................... 161
,Chapter n,42. n,Hyperlipidemia ........................................................................................................................ 164
Chapter n,43. n,Hypertension............................................................................................................................ 169
Chapter n,44. n,Hyperthyroidism n,and n,Hypothyroidism .................................................................................... 174
Chapter n,45. n,Obesity .................................................................................................................................... 177
Chapter n,46. n,Pain n,Management: n,Acute n,and n,Chronic n,Pain........................................................................... 181
Chapter n,47. n,Pneumonia ............................................................................................................................... 185
Chapter n,48. n,Sexually n,Tr n,ANS n,mitted n,Diseases n,and n,Vaginitis ................................................................... 187
Chapter n,49. n,Substance n,Use n,Disorders......................................................................................................... 190
Chapter n,50. n,Tuberculosis ............................................................................................................................ 195
Chapter n,51. n,Upper n,Respiratory n,Tract n,Infection, n,Pharyngitis, n,Sinusitis, n,Otitis n,Media, n,and n,Otitis n,Externa ... 197
Chapter n,52. n,Urinary n,Tract n,Infections.......................................................................................................... 200
Chapter n,53. n,Women n,as n,Patients.................................................................................................................. 203
Chapter n,54. n,Men n,as n,Patients....................................................................................................................... 207
Chapter n,55. n,Pediatric n,Patients ..................................................................................................................... 209
Chapter n,57. n,Geriatric n,Patients ..................................................................................................................... 213
, 1
Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
n, n, n, n, n, n, n, n, n, n,
MULTIPLE n,CHOICE
1. Nurse n,practitioner n,prescriptive n,authority n,is n,regulated n,by:
A. The n,National n,Council n,of n,State n,Boards n,of n,Nursing
B. The n,U.S. n,Drug n,Enforcement n,Administration
C. The n,State n,Board n,of n,Nursing n,for n,each n,state
D. The n,State n,Board n,of n,Pharmacy
n, ANS n,: n , C PTS: n , n, 1
2. The n,benefits n,to n,the n,patient n,ofn,having n,an n,advanced n,practice n,registered n,nurse n,(APRN)
prescriber n,include:
n,
A. Nurses n,know n,more n,about n,pharmacology n,than n,other n,prescribers n,because n,they n,take
n,it n, both n, in n,their n, basic n, nursing n,program n,and n, in n,their n, APRN n,program.
B. Nurses n,care n,for n,the n,patient n,from n,a n,holistic n,approach n,and n,include n,the
n,patient n,in n,decision-making n,regarding n,their n,care.
C. APRNs n,are n,less n,likely n,to n,prescribe n,narcotics n,and n,other n,controlledn,substances.
D. APRNs n,are n,able n,to n,prescribe n,independently n,in n,all n,states, n,whereas n,a
n,physician’s n,assistant n, needs n,to n,have n, a n,physician n, supervising n,their n,practice.
n, ANS n,: n , B PTS: n , n, 1
3. Clinical n,judgment n,in n,prescribing n,includes:
A. Factoring n,in n,the n,cost n,to n,the n,patient n,of n,the n,medication n,prescribed
B. Always n,prescribing n,the n,newest n,medication n,available n,for n,the n,disease n,process
C. Handing n,out n,drug n,samples n,to n,poor n,patients
D. Prescribing n,all n,generic n,medications n,to n,cut n,costs
n, ANS n,: n , A PTS: n , n, 1
4. The n,process n,for n,choosing n,an n,effective n,drug n,for n,a n,disorder n,includes:
A. Asking n,the n,patient n,what n,drug n,they n,think n,would n,work n,best n,for n,them
B. Consulting n,nationally n,recognized n,guidelines n,for n,disease n,management
C. Prescribing n,medications n,that n,are n,available n,as n,samples n,before n,writing n,a n,prescription
D. Following n,U.S. n,Drug n,Enforcement n,Administration n,guidelines n,for n,prescribing
n, ANS n,: n , B PTS: n , n, 1
5. Nonintentional n,nonadherence n,of n,drug n,therapy n,may n,occur n,due n,to:
A. Belief n,that n,medication n,does n,not n,work
B. Adverse n,drug n,reactions
C. Chronic n,conditions n,that n,require n,daily n,therapy
D. Forgetfulness n,or n,distraction
n, ANS n,: n , D PTS: n , n, 1
